---
layout: talk_reveal3
title: SARS-CoV-2 variants of concern
venue: Fred Hutch
author: Trevor Bedford
widescreen: true
---

<!-- Outline:
-
-->

<!-- Presentation time of 10 to 15 minutes -->

<section data-background-iframe="/talks/viz/gradient/">
	<h2 class="title">{{ page.title }}</h2>
	<br>&nbsp;<br>
	<p class="title">
	Trevor Bedford (@trvrb)
	<br>
	Associate Professor
	<br>
	{{ page.venue }}, Seattle, WA
	<br>
	{{ page.date | date: "%-d %b %Y" }}
	<br>&nbsp;<br>
	Slides at: bedford.io/talks
</section>

<section class="left-align">
	<h2>1. Evolutionary origins of variant viruses</h2>
	<h2>2. Implications for unfolding pandemic</h2>
</section>

<section data-background="#000000">
	<h1 class="title">Evolutionary origins</h1>
</section>

<section>
	<h3>Over 300k SARS-CoV-2 genomes shared and evolution tracked in real-time at nextstrain.org</h3>
	<img class="stretch" data-src="/images/talks/ncov_tree_map_2021_01_12_global.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<!-- The S1 subunit contains a receptor-binding domain that recognizes and binds to the
host receptor angiotensin-converting enzyme 2 ACE-2, while the S2 subunit mediates viral
cell membrane fusion by forming a six-helical bundle via the two-heptad repeat domain. -->

<section>
	<h3>Spike protein is critical for cell invasion by the virus and is the primary target for human immune response</h3>
	<img class="stretch" data-src="/images/talks/sars_cov_2_spike_structure.png">
	<div class="citation">
		<a href="https://science.sciencemag.org/content/367/6483/1260">Wrapp et al. 2020. Science.</a>
	</div>
</section>

<section>
	<h3>484K and 501Y repeatedly emerging across the world</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_484K_501Y_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V1 in the UK</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V1_clock_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V2 in the South Africa</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V2_clock_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Emergence of 501Y.V3 in the Brazil</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V3_clock_2021_01_12.png">
	<div class="citation">
		<a href="https://nextstrain.org">nextstrain.org</a>
	</div>
</section>

<section class="left-align">
	<h3>
		Three occurences makes a pattern.
		Working hypothesis of rare events occurring during chronic infection,
		driven by natural selection for immune escape.
	</h3>
</section>

<section data-background="#000000">
	<h1 class="title">Pandemic implications</h1>
</section>

<section class="left-align" data-transition="slide-in none-out">
	<h3>Three different phenotypic traits may be affected</h3>
	<p>
	<ol>
		<li>Transmissibility</li>
		<li>Severity</li>
		<li>Antigenicity</li>
	</ol>
	</p>
</section>

<section class="left-align" data-transition="none-in slide-out">
	<h3>Three different phenotypic traits may be affected</h3>
	<p>
	<ol>
		<li>Transmissibility <i>(strong evidence for increase)</i></li>
		<li>Severity <i>(weak evidence for little change)</i></li>
		<li>Antigenicity <i>(moderate evidence for partial immune escape)</i></li>
	</ol>
	</p>
</section>

<section>
	<h3>Rapid increase in prevalence of 501Y.V1 in the UK consistent with 50% greater transmissibility</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V1_prevalence_davies.png">
	<div class="citation">
		<a href="https://cmmid.github.io/topics/covid19/uk-novel-variant.html">Davies et al. 2020.</a>
	</div>
</section>

<section>
	<h3>Contacts of 501Y.V1 cases more likely to become infected</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V1_sar_phe.png">
	<div class="citation">
		<a href="https://www.gov.uk/government/publications/investigation-of-novel-sars-cov-2-variant-variant-of-concern-20201201">Public Health England. 2020.</a>
	</div>
</section>

<section>
	<h3>Increased viral load of 501Y.V1 circulating in the UK</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V1_viral_load.jpg">
	<div class="citation">
		<a href="https://www.medrxiv.org/content/10.1101/2020.12.24.20248834v1">Kidd et al. 2020. medRxiv.</a>
	</div>
</section>

<section class="left-align">
	<h3>
		Matched cohort study by Public Health England suggests not a large difference in outcomes between 501Y.V1 cases and wildtype cases.
		However, number of outcomes recorded is small.
	</h3>
</section>

<section>
	<h3>Mutations in 501Y.V2 circulating in South Africa impact antibody binding (501Y.V1 in the UK is less of a concern)</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_501Y.V2_structure.png">
	<div class="citation">
		<a href="https://www.medrxiv.org/content/10.1101/2020.12.21.20248640v1">Tegally et al. 2020. medRxiv.</a>
	</div>
</section>

<section>
	<h3>Strong immune response to mRNA vaccines may help here</h3>
	<img class="stretch" data-src="/images/talks/sars_cov_2_bnt162b_titers.jpg">
	<div class="citation">
		<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2027906">Walsh et al. 2020. NEJM.</a>
	</div>
</section>

<section class="left-align">
	<h3>
		I still expect 2021 to bring the pandemic under control through vaccination and natural infection, but perhaps with a rockier start than I had imagined just 3 weeks ago.
	</h3>
</section>
